The impact of anastomotic leakage on oncologic outcomes and the receipt and timing of adjuvant chemotherapy after colorectal cancer surgery

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purposes: To evaluate the impact of anastomotic leakage on oncologic outcomes in patients with colorectal cancer. We also evaluated the influence of anastomotic leakage on receipt and commencement time of adjuvant chemotherapy. Methods: A total of 809 consecutive patients undergoing major resection for colorectal cancer were categorized into leak (n = 33, 4.1%) and non-leak (n = 776, 95.9%) groups. Results: The 5-year local recurrence rates of stage II disease were 0.6% and 20.0% for non-leak and leak groups respectively (p = 0.046), and the equivalent rates for stage III disease were 9.1% and 59.4% respectively (p < 0.001). For stage III disease, receipt of adjuvant therapy was lower in the leak group (63% vs. 87%, p = 0.007) and mean time to initiation of chemotherapy was longer in the leak group (52 days vs. 37 days) but this did not reach statistical significance (p = 0.080). Older age (hazard ratio [HR] = 2.8), advanced TNM classification (HR = 3.6), and anastomotic leakage (HR = 8.9) were adverse risk factors for local recurrence based on multivariate analysis. Conclusions: Anastomotic leakage adversely influenced local recurrence rates in stage II and III disease and was an independent risk factor for local recurrence. Additionally, anastomotic leakage contributed to failure to receive adjuvant chemotherapy in patients with stage III disease.

Original languageEnglish
Article number2114
Pages (from-to)3-9
Number of pages7
JournalInternational Journal of Surgery
Volume22
DOIs
Publication statusPublished - 2015 Oct

Fingerprint

Colorectal Surgery
Anastomotic Leak
Adjuvant Chemotherapy
Colorectal Neoplasms
Recurrence
Neoplasm Staging
Multivariate Analysis
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

@article{8108a78ac4b741f2a51cde9e3842ce81,
title = "The impact of anastomotic leakage on oncologic outcomes and the receipt and timing of adjuvant chemotherapy after colorectal cancer surgery",
abstract = "Purposes: To evaluate the impact of anastomotic leakage on oncologic outcomes in patients with colorectal cancer. We also evaluated the influence of anastomotic leakage on receipt and commencement time of adjuvant chemotherapy. Methods: A total of 809 consecutive patients undergoing major resection for colorectal cancer were categorized into leak (n = 33, 4.1{\%}) and non-leak (n = 776, 95.9{\%}) groups. Results: The 5-year local recurrence rates of stage II disease were 0.6{\%} and 20.0{\%} for non-leak and leak groups respectively (p = 0.046), and the equivalent rates for stage III disease were 9.1{\%} and 59.4{\%} respectively (p < 0.001). For stage III disease, receipt of adjuvant therapy was lower in the leak group (63{\%} vs. 87{\%}, p = 0.007) and mean time to initiation of chemotherapy was longer in the leak group (52 days vs. 37 days) but this did not reach statistical significance (p = 0.080). Older age (hazard ratio [HR] = 2.8), advanced TNM classification (HR = 3.6), and anastomotic leakage (HR = 8.9) were adverse risk factors for local recurrence based on multivariate analysis. Conclusions: Anastomotic leakage adversely influenced local recurrence rates in stage II and III disease and was an independent risk factor for local recurrence. Additionally, anastomotic leakage contributed to failure to receive adjuvant chemotherapy in patients with stage III disease.",
author = "Kim, {Ik Yong} and Kim, {Bo Ra} and Kim, {Young Wan}",
year = "2015",
month = "10",
doi = "10.1016/j.ijsu.2015.08.017",
language = "English",
volume = "22",
pages = "3--9",
journal = "International Journal of Surgery",
issn = "1743-9191",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The impact of anastomotic leakage on oncologic outcomes and the receipt and timing of adjuvant chemotherapy after colorectal cancer surgery

AU - Kim, Ik Yong

AU - Kim, Bo Ra

AU - Kim, Young Wan

PY - 2015/10

Y1 - 2015/10

N2 - Purposes: To evaluate the impact of anastomotic leakage on oncologic outcomes in patients with colorectal cancer. We also evaluated the influence of anastomotic leakage on receipt and commencement time of adjuvant chemotherapy. Methods: A total of 809 consecutive patients undergoing major resection for colorectal cancer were categorized into leak (n = 33, 4.1%) and non-leak (n = 776, 95.9%) groups. Results: The 5-year local recurrence rates of stage II disease were 0.6% and 20.0% for non-leak and leak groups respectively (p = 0.046), and the equivalent rates for stage III disease were 9.1% and 59.4% respectively (p < 0.001). For stage III disease, receipt of adjuvant therapy was lower in the leak group (63% vs. 87%, p = 0.007) and mean time to initiation of chemotherapy was longer in the leak group (52 days vs. 37 days) but this did not reach statistical significance (p = 0.080). Older age (hazard ratio [HR] = 2.8), advanced TNM classification (HR = 3.6), and anastomotic leakage (HR = 8.9) were adverse risk factors for local recurrence based on multivariate analysis. Conclusions: Anastomotic leakage adversely influenced local recurrence rates in stage II and III disease and was an independent risk factor for local recurrence. Additionally, anastomotic leakage contributed to failure to receive adjuvant chemotherapy in patients with stage III disease.

AB - Purposes: To evaluate the impact of anastomotic leakage on oncologic outcomes in patients with colorectal cancer. We also evaluated the influence of anastomotic leakage on receipt and commencement time of adjuvant chemotherapy. Methods: A total of 809 consecutive patients undergoing major resection for colorectal cancer were categorized into leak (n = 33, 4.1%) and non-leak (n = 776, 95.9%) groups. Results: The 5-year local recurrence rates of stage II disease were 0.6% and 20.0% for non-leak and leak groups respectively (p = 0.046), and the equivalent rates for stage III disease were 9.1% and 59.4% respectively (p < 0.001). For stage III disease, receipt of adjuvant therapy was lower in the leak group (63% vs. 87%, p = 0.007) and mean time to initiation of chemotherapy was longer in the leak group (52 days vs. 37 days) but this did not reach statistical significance (p = 0.080). Older age (hazard ratio [HR] = 2.8), advanced TNM classification (HR = 3.6), and anastomotic leakage (HR = 8.9) were adverse risk factors for local recurrence based on multivariate analysis. Conclusions: Anastomotic leakage adversely influenced local recurrence rates in stage II and III disease and was an independent risk factor for local recurrence. Additionally, anastomotic leakage contributed to failure to receive adjuvant chemotherapy in patients with stage III disease.

UR - http://www.scopus.com/inward/record.url?scp=84943537454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943537454&partnerID=8YFLogxK

U2 - 10.1016/j.ijsu.2015.08.017

DO - 10.1016/j.ijsu.2015.08.017

M3 - Article

C2 - 26283295

AN - SCOPUS:84943537454

VL - 22

SP - 3

EP - 9

JO - International Journal of Surgery

JF - International Journal of Surgery

SN - 1743-9191

M1 - 2114

ER -